TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/5/24 16:46 | 11/1/24 | TECH | Bio-Techne Corp | MN | Health | BioPrd | Biological Products, (No Diag | Hippel James | MN | O | CFO | M.d | 0 | 0.00 | 0 | 13 | 14 | 107 | D | ||||||||||||||
8/6/24 16:23 | 8/2/24 | TECH | Bio-Techne Corp | MN | Health | BioPrd | Biological Products, (No Diag | Hippel James | MN | O | CFO | M.d | 1,657 | 31.26 | 0 | 53 | 113 | 100 | D | ||||||||||||||
7/25/24 16:31 | 7/23/24 | TECH | Bio-Techne Corp | MN | Health | BioPrd | Biological Products, (No Diag | Hippel James | MN | O | CFO | M.d | 1,094 | 31.26 | 0 | 35 | 73 | 83 | D | ||||||||||||||
12/21/23 16:06 | 12/19/23 | TECH | Bio-Techne Corp | MN | Health | BioPrd | Biological Products, (No Diag | Hippel James | MN | O | CFO | M.d | 1,478 | 31.26 | 0 | 47 | 192 | 72 | D | ||||||||||||||
8/8/23 17:29 | 8/5/23 | TECH | Bio-Techne Corp | MN | Health | BioPrd | Biological Products, (No Diag | Hippel James | MN | O | CFO | M.d | 0 | 0.00 | 0 | 13 | 29 | 58 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |